Published in Vaccine Weekly, August 22nd, 2007
"Therefore, vaccines designed to prevent infection with oncogenic HPV types have the potential to decrease morbidity and mortality associated wit cervical cancer and precancerous lesions. Vaccinology research recently has developed tools that may be used...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly